Molecular genetics of too much bone
- PMID: 12351574
- DOI: 10.1093/hmg/11.20.2385
Molecular genetics of too much bone
Abstract
Bone remodelling is an important process both throughout growth and in adult life. The homeostasis of bone tissue is maintained by the balanced processes of bone resorption and formation. Imbalance can give rise to a broad spectrum of skeletal pathologies, of which osteoporosis, characterized by a decrease in bone density leading to increased fracture risk, is the best known because of its high prevalence and consequently high socio-economic impact. At the opposite end of the spectrum, several genetic conditions displaying too much bone are situated. Mainly because of their monogenic nature-in contrast to the multifactorial character of osteoporosis-the underlying molecular genetic causes for several of these conditions have been revealed recently. In this review, the most important gene identifications of the last years and their impact on the understanding of bone biology are discussed.
Similar articles
-
MECHANISMS IN ENDOCRINOLOGY: Genetics of human bone formation.Eur J Endocrinol. 2017 Aug;177(2):R69-R83. doi: 10.1530/EJE-16-0990. Epub 2017 Apr 5. Eur J Endocrinol. 2017. PMID: 28381451 Review.
-
Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.Curr Osteoporos Rep. 2014 Sep;12(3):243-51. doi: 10.1007/s11914-014-0220-5. Curr Osteoporos Rep. 2014. PMID: 24947952 Review.
-
Bone turnover markers in the management of postmenopausal osteoporosis.Clin Biochem. 2009 Jul;42(10-11):929-42. doi: 10.1016/j.clinbiochem.2009.04.001. Epub 2009 Apr 10. Clin Biochem. 2009. PMID: 19362543 Review.
-
Perspectives on osteoporosis therapies.J Endocrinol Invest. 2015 Mar;38(3):303-11. doi: 10.1007/s40618-014-0236-9. Epub 2015 Jan 11. J Endocrinol Invest. 2015. PMID: 25577263 Review.
-
[On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Cellular mechanism and etiology of osteoporosis].Clin Calcium. 2015 Sep;25(9):1293-300. Clin Calcium. 2015. PMID: 26320528 Japanese.
Cited by
-
Molecular Basis for Craniofacial Phenotypes Caused by Sclerostin Deletion.J Dent Res. 2021 Mar;100(3):310-317. doi: 10.1177/0022034520963584. Epub 2020 Oct 20. J Dent Res. 2021. PMID: 33078679 Free PMC article.
-
Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.PLoS One. 2013 Apr 29;8(4):e62295. doi: 10.1371/journal.pone.0062295. Print 2013. PLoS One. 2013. PMID: 23638027 Free PMC article.
-
Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.Cell Mol Life Sci. 2015 Apr;72(7):1347-61. doi: 10.1007/s00018-014-1801-2. Epub 2014 Dec 9. Cell Mol Life Sci. 2015. PMID: 25487608 Free PMC article. Review.
-
Genetic analysis of autosomal recessive osteopetrosis in Chuvashiya: the unique splice site mutation in TCIRG1 gene spread by the founder effect.Eur J Hum Genet. 2009 May;17(5):664-72. doi: 10.1038/ejhg.2008.234. Epub 2009 Jan 28. Eur J Hum Genet. 2009. PMID: 19172990 Free PMC article.
-
Varus deformity of the left lower extremity causing degenerative lesion of the posterior horn of the left medial meniscus in a patient with Paget's disease of bone.Ger Med Sci. 2014 Sep 25;12:Doc13. doi: 10.3205/000198. eCollection 2014. Ger Med Sci. 2014. PMID: 25276115 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources